 |
Bulletin Board
Volume 13, Number 1 (June, 1998) |
New Branch Chief Oversees Health Services Research
|
Dr. Bennett Fletcher has been named chief of the Services Research Branch (SRB) within NIDA's Division of Clinical and Services Research. As SRB chief, he directs NIDA's program of health services research on drug abuse treatment, including the impact of financing, organization, and management on treatment quality, cost, and outcomes.
Dr. Fletcher is a principal investigator in NIDA's Drug Abuse Treatment Outcome Study (DATOS), a nationwide study of drug abuse treatment outcomes. (For more information on DATOS, see NIDA NOTES, September/October 1997.) He also has supported programs of research on treating those in the criminal justice system, and on treating vulnerable populations, including adolescents, women, and those at risk for HIV infection.
|
Dr. Bennett Fletcher |
Coming Up...
July 27-28, 1998
Bethesda, Maryland
This conference is sponsored by NIDA and the Robert Wood Johnson Foundation and cosponsored by the National Cancer Institute and the Office on Smoking and Health of the Centers for Disease Control and Prevention. Topics will include:
- genetic, biological, behavioral, and sociocultural factors in tobacco use;
- breakthroughs in the neurobiology of nicotine addiction;
- risk and protective factors for nicotine addiction;
- new medications and behavioral techniques for treating nicotine addiction; and
- strategies for preventing children and adolescents from using
- tobacco.
For more information, contact Robin Bowie Semsker, Capital Consulting Corporation, phone: (301) 468-6004, ext. 431; e-mail: rsemsker@md.capconcorp.com.
12th World AIDS Conference
June 28-July 3, 1998
Geneva, Switzerland
The World AIDS Conference is the world's leading forum for information on HIV/AIDS in the areas of basic and clinical research, treatment, and prevention. This year, NIDA is involved in the scientific planning of the conference and is providing travel scholarships for drug abuse researchers from resource-poor countries. For more information contact: Congrex Sweden AB, AIDS 98, P.O. Box 5619, Linnégatan 89A, SE-114 86 Stockholm, Sweden, phone: 011 46 8 459 6600, e-mail: aids98registration@congrex.se.
|
Newest NIDA Monograph Discusses Clinical Trials for Cocaine Medications
Monograph 175 (online)
|
NIDA has published a new NIDA Research Monograph titled Medication Development for the Treatment of Cocaine Dependence: Issues in Clinical Efficacy. The papers in the monograph were first presented at a NIDA technical review meeting at which scientists discussed the difficulties in evaluating the results from different clinical trials of potential cocaine treatment medications. These difficulties have arisen because of a lack of standardization in the research methodology.
The monograph is intended as a guidebook for researchers interested in conducting clinical trials of these medications. The papers in the monograph include an overview of the rationale for the development of these medications and a comprehensive review of the compounds that have been tested. Also included are discussions of methodological issues involved in conducting clinical trials of treatment medications for cocaine dependence, such as identifying meaningful outcome measures and clinically relevant success criteria. Several papers examine the use of urinanalysis of cocaine metabolite levels to monitor treatment effectiveness.
The monograph, which is number 175 in the series of NIDA Research Monographs, was edited by Dr. Betty Tai, Dr. Nora Chiang, and Dr. Peter Bridge of NIDA's Medications Development Division. This free publication is available from the National Clearinghouse for Alcohol and Drug Information, P.O. Box 2345, Rockville, MD 20847, at 1-800-729-6686. The monograph can also be downloaded from the NIDA home page on the World Wide Web at: http://www.nida.nih.gov/PubCat/PubsIndex.html.
|
|
NIDA NOTES - Volume 13 Number 1 |
[NIDA Home Page][NIDA NOTES Index][Index of this Issue]
|
|
